PALAVRAS EM INGLÊS RELACIONADAS COM «BULLOUS»
bullous
skin
diseases
lung
disease
myringitis
keratopathy
lupus
pronunciation
impetigo
emphysema
cutaneous
condition
medical
that
affects
integumentary
system
organ
encloses
body
includes
bullous
pemphigoid
mayo
goid
rare
causes
large
fluid
filled
blisters
areas
flex
such
lower
health
patient
mainly
people
aged
over
treatment
usually
works
control
symptoms
merriam
webster
resembling
characterized
bullae
vesicular
lesions
first
lous
adjective
ˈbu̇l
facts
blistery
information
about
more
dermnet
authoritative
from
zealand
management
medscape
reference
other
autoimmune
goal
therapy
decrease
blister
formation
promote
healing
10 LIVROS EM INGLÊS RELACIONADOS COM «BULLOUS»
Descubra o uso de
bullous na seguinte seleção bibliográfica. Livros relacionados com
bullous e pequenos extratos deles para contextualizar o seu uso na literatura.
1
Atlas of
Bullous Disease
The research performed on these skin diseases is on of the most exciting stories in dermatology over the last two to three decades.
2
Bullous Pemphigoid: New Insights for the Healthcare ...
The editors have built Bullous Pemphigoid: New Insights for the Healthcare Professional: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Additional Research in this book to be deeper ...
3
Clinical Outline of Oral Pathology: Diagnosis and Treatment
As in the other oral bullous disorders, rupture with desquamation takes place
shortly after the lesions appear. The disease is annoying yet not usually fatal;
nevertheless, septicemia may be a complication. There is some evidence that
patients ...
4
Autoimmune Diseases of the Skin: Pathogenesis, Diagnosis, ...
Taylor G, Venning V, Wojnarowska F, Welch K (1993) Bullous pemphigoid and
autoimmunity. J Am Acad Dermatol 29:181–184 Thoma-Uszynski S, Uter W,
Schwietzke S, Hofmann SC, Hunziker T, Bernard P, Treudler R, Zouboulis CC, ...
5
Diagnosis of Aging Skin Diseases
The primary lesion in bullous diseases is a vesicle (0.1–1cm) or bulla (> 1cm).
Although these diseases affect patients in all age groups, the elderly are
particularly susceptible. Bullous diseases may be divided into five subgroups
based on the ...
A.M. Kligman, Robert A. Norman, 2008
6
Atlas of
Bullous Diseases
This highly illustrated text from a world pioneer in research and treatment for some of these diseases will be of great value in setting out the criteria for diagnosis and management.
7
Life-Threatening Dermatoses and Emergencies in Dermatology
Giudice GJ, Emery DJ, Diaz LA (1992) Cloning and primary structural analysis of
the bullous pemphigoid autoanti- gen BP180. J Invest Dermatol 99:243–250 2.
Stanley JR (1989) Pemphigus and pemphigoid as paradigms of organ-specific, ...
Jean Revuz, Jean-Claude Roujeau, Francisco Kerdel, 2009
8
A Clinician's Pearls & Myths in Rheumatology
The patient's rash cleared with topical antifungal cream (Figure courtesy of Dr.
Grant Anhalt) Pearl: Bullous lupus erythematosus (LE) and epidermolysis bullosa
acquisita are actually the same disease from the standpoint of the skin. Comment
: ...
9
Genital Dermatology Atlas
The blisters of bullous pemphigoid occur from a deeper cleft in the skin, under the
epidermis, resulting in tense, straw-colored blisters, rather than flaccid lesions. (
Credit Errol Craig, MD.) biopsy of perilesional skin shows in vivo deposition of ...
Libby Edwards, Peter J. Lynch, 2010
10
Mayo Clinic Internal Medicine Concise Textbook
Autoimmune Bullous Diseases Bullous pemphigoid (Fig. 5-1) is the most
common autoimmune bullous disease. The disease predominantly occurs in
elderly patients and usually presents with large, tense bullae on an erythematous
base with ...
Thomas M. Habermann, Amit K. Ghosh, 2007
10 NOTÍCIAS NAS QUAIS SE INCLUI O TERMO «BULLOUS»
Conheça de que se fala nos meios de comunicação nacionais e internacionais e como se utiliza o termo
bullous no contexto das seguintes notícias.
Phase 2 clinical trials underway in ulcerative colitis, bullous …
Immune Pharmaceuticals announced initiation of two phase 2 studies looking at bertilimumab in ulcerative colitis and bullous pemphigoid. «Healio, jul 15»
Immune Pharmaceuticals Signs License & Research Agreement for …
... moderate to severe ulcerative colitis and Crohn's disease as well as bullous pemphigoid, an orphan auto-immune dermatological condition. «PR Newswire, jun 15»
Early resolution of subretinal fluid without high-dose corticosteroids …
To our knowledge, this report describes the shortest healing period for bilateral bullous retinal detachment in a pregnant woman with VKH ... «7thSpace Interactive, jun 15»
Immune Pharmaceuticals begins bertilimumab Phase II clinical trials …
The first two Phase II clinical trials with bertilimumab in Bullous Pemphigoid and Ulcerative Colitis are expected to provide guidance on further ... «News-Medical.net, jun 15»
AQXP Fails To Lead, Concordia To Get Better Visibility, EXAC Gets …
The phase II Bullous Pemphigoid clinical trial with Bertilimumab is designed as an open label clinical trial in 10 patients, with moderate to ... «RTT News, jun 15»
StockNewsNow.com Publishes New SNNLive Video Interview With …
... moderate to severe ulcerative colitis and Crohn's disease as well as bullous pemphigoid, an orphan auto-immune dermatological condition. «MarketWatch, jun 15»
Bullous scabies: a case report and review of the literature
A rare presentation of scabies is the bullous pemphigoid-like bullous scabies. So far, to the best of our knowledge, only 32 cases of bullous ... «7thSpace Interactive, jun 15»
Results From Phase 3 Trial Show Vectibix® (Panitumumab …
... abscesses, and sepsis have been observed in patients treated with Life-threatening and fatal bullous mucocutaneous disease with blisters, ... «MarketWatch, jun 15»
Updated Results from MM-020/IFM 07-01 (First) Study of REVLIMID …
REVLIMID must be discontinued for angioedema, Grade 4 rash, exfoliative or bullous rash, or if SJS or TEN is suspected and should not be ... «Business Wire, jun 15»
Immune Pharmaceuticals Successfully Incorporates Cyclosporine A …
... Daniel Teper, the CEO of Immune Pharmaceuticals, commented: "Following our lead product candidate bertilimumab in bullous pemphigoid, ... «AZoNano.com, jun 15»
